[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"colon-cancer-screening\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:colon-cancer-screening":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,42,74,97],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":4},"100640657","community-gateway-to-health-study-100640657",false,"NCT07592793","Community Gateway to Health Study","Study participants include community health center and community partner staff participating in surveys and interviews about the implementation of the intervention.\n\nInclusion Criteria:\n\n* Community health center staff or community partners\n* Age 18 or older\n\nExclusion Criteria:\n\n* Under 18\n\nPatients will not be individually recruited for the study because the intervention is being offered as part of routine care.",true,"ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this study is to evaluate the impact of a multi-level intervention on cancer prevention and social determinants of health outcomes. This partnership between academic and community-based researchers aims to link community health centers and communities in ways that maximize both civic engagement and participation in cancer control care. The system-level intervention consists of two components: (1) provision of community health center systems-level tools for cancer screening (breast, cervical, colorectal) and tobacco cessation treatment gaps; and (2) digital access screening and navigation. These interventions will be delivered via usual care.",[26,27,28,29],"Breast Cancer Screening","Cervical Cancer Screening","Colon Cancer Screening","Tobacco Cessation","NOT_YET_RECRUITING","2026-05-11",{"date":33,"type":34},"2026-05-18","ACTUAL",{"date":36,"type":20},"2026-06",{"date":38,"type":20},"2029-07",{"name":40,"class":41},"Harvard School of Public Health (HSPH)","OTHER",{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":15,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":69,"leadSponsor":71,"locationsCount":73},"100610470","bundled-cancer-screening-and-genetic-services-navigation-100610470","NCT07228000","Bundled Cancer Screening and Genetic Services Navigation","Inclusion Criteria:\n\n1. Seeking screening navigation services through programs at a participating site (Georgetown Lombardi Cancer Center or Helen F. Graham Cancer Center \\& Research Institutes)\n2. Eligible for breast cancer screening while also due and eligible for colorectal cancer screening (per USPSTF guidelines)\n3. Female sex\n4. Aged 45-74\n5. Identify as Black\u002FAfrican American race and\u002For Hispanic\u002FLatin(e)(a) ethnicity\n6. Speak English or Spanish with enough fluency to complete study activities\n7. Stated willingness to comply with all study procedures (navigation, surveys) and availability for the duration of the study\n8. Provision of completed electronic informed consent form\n\nExclusion Criteria:\n\n1. Not engaged with or planning to use navigation programs at Georgetown Lombardi Cancer Center and Helen F. Graham Cancer Center \\& Research Institute\n2. Not eligible for breast cancer screening or not due and eligible for colorectal cancer screening (per USPSTF guidelines)\n3. History of breast and\u002For colorectal cancer; or Reporting symptoms related to breast and\u002For colorectal cancer (e.g., GI bleeding, breast mass)\n4. Male sex, Intersex, or other sex\n5. Under age 45 or over age 74\n6. Identifies as neither Black\u002FAfrican American race nor Hispanic\u002FLatin(e)(a) ethnicity\n7. Speaks neither English nor Spanish with enough fluency to complete study activities\n8. Stated unwillingness to comply with study procedures (navigation, surveys) or unavailability for the duration of the study\n9. Inability to provide electronic informed consent, or needing another person to authorize informed consent on their behalf","FEMALE","45 Years","74 Years",{"count":52,"type":20},820,[23],"The goal of this study is to test bundled familial cancer risk assessment + multicancer (colorectal + breast) vs. single (breast) cancer navigation, using a wait list control for colorectal cancer screening referral and navigation. Among those eligible, this study will test usual care referral to genetic services vs. pretest education + usual care referral. The study also will assess how bundled multicancer navigation works and for whom it is most effective through a multisite, mixed-methods patient- and organization-level process evaluation.",[26,28,56],"Genetics Predisposition",[58,59,60,61,62,63],"navigation","mammography","colonoscopy","Fecal Immunochemical Test","genetic testing","risk assessment","RECRUITING","2026-05-06",{"date":67,"type":34},"2026-05-08",{"date":65,"type":34},{"date":70,"type":20},"2029-05-31",{"name":72,"class":41},"Georgetown University",2,{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":4,"eligibilityCriteria":80,"healthyVolunteers":15,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":81,"targetDuration":4,"studyType":21,"phases":83,"briefSummary":85,"conditions":86,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":90,"completionDateStruct":91,"leadSponsor":93,"locationsCount":96},"100619930","phase-4-colonoscopy-bowel-prep-comparison-among-diabetic-patients-100619930","NCT07351019","Colonoscopy Bowel Prep Comparison Among Diabetic Patients","Colonoscopy Bowel Prep Comparison Among Diabetic Patients: Golytely v. SUPREP","Inclusion Criteria:\n\n1. Participants having provided informed consent with signature on informed consent form: the informed consent process should be complete with full discussion of all requirements and possible risks.\n2. Diabetic volunteer (defined per current ACP guidelines, and any type of DM)\n3. Aged 18+ years, inclusive\n4. Average screening risk, polyp surveillance, and family history of cancer\n\nExclusion Criteria:\n\n1. Unable to provide informed consent to participate in the study Such as a mental condition rendering the participant unable to understand the nature, scope, and possible consequences of the study\n2. Clinically relevant cardiovascular, hepatic, neurological, endocrine, or other major systemic disease making implementation of the protocol or interpretation of the study results difficult or that would put the participant at risk by participating in the study\n3. Persistent significant or severe infection, either acute or chronic\n4. Prior use of any investigational drug in the preceding 6 months\n5. Liver function impairment or persisting elevations (confirmed by retest) of alanine aminotransferase (ALT), aspartate aminotransferase (AST), or direct bilirubin greater than 2x the upper limit of normal range (ULN).\n6. Pregnant or breast-feeding women or those who plan to become pregnant during the study\n7. Participants with significantly impaired bone marrow function or significant anemia, leukopenia, or thrombocytopenia (confirmed by retest):\n\n   1. Hematocrit \\\u003C 35% and\u002For\n   2. Absolute white blood cell count \\\u003C 3000 cells\u002Fmm3 ( L) and\u002For\n   3. Platelet count \\\u003C 150 000 cells\u002Fmm3 ( L) and\u002For- Absolute neutrophil = 1500 cells\u002Fmm3 ( L)\n8. History of colorectal cancer\n9. Inflammatory Bowel Disease\n10. Past surgical history of colon resection\n11. Prior history of colorectal surgery\n12. Family history of hereditary polyposis and cancer disorders to include but not limited to FAP (Familial Adenomatous Polyposis), Gardner Syndrome, Turcot Syndrome, Lynch Syndrome, Cowden Syndrome, and Peutz-Jeghers Syndrome\n13. Symptomatic patients (bleeding, diarrhea, constipation, abdominal pain)",{"count":82,"type":20},80,[84],"PHASE4","The goal of this clinical trial is to learn if the Golytely or SUPREP bowel preparation works more effectively in bowel cleansing for colorectal cancer screening with colonoscopy in patients with diabetes. The main questions this study aims to answer are:\n\n1. Is there a significant difference in bowel prep cleanse between Golytely and SUPREP in patients with diabetes based on the Boston Bowel Prep Score (BBPS) as assessed by blinded, skilled endoscopists?\n2. Is there a significant difference in patients' tolerance between the bowel preparations as assessed by the validated Mayo Bowel Prep Tolerability Form (MBPTF)?\n\nParticipants will:\n\n* Be randomized to take either Golytely or SUPREP bowel preparation prior to their colonoscopy\n* Complete the MBPTF on the procedure date prior to the scheduled colonoscopy\n* Undergo a standardized screening colonoscopy during which time a blinded endoscopist will document the participant's BBPS\n\nThe research team hypothesizes that SUPREP will have a significant difference in tolerability (based on MBPTF), while exhibiting no difference in bowel cleanse (based on BBPS) in the diabetic patient population.",[28],"2026-01-16",{"date":89,"type":34},"2026-01-20",{"date":87,"type":20},{"date":92,"type":20},"2026-07-28",{"name":94,"class":95},"Eisenhower Army Medical Center","FED",1,{"id":98,"slug":99,"hasResults":11,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":4,"eligibilityCriteria":103,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":104,"enrollmentInfo":105,"targetDuration":4,"studyType":21,"phases":107,"briefSummary":108,"conditions":109,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":4},"100611791","randomized-control-trial-comparing-the-incidence-of-loop-formation-in-colonoscopy-techniques-100611791","NCT07245173","Randomized Control Trial Comparing the Incidence of Loop Formation in Colonoscopy Techniques","Randomized Control Trial Comparing the Incidence of Loop Formation in Water Infusion Versus Air Insufflation Colonoscopy Techniques","Inclusion Criteria:\n\n* Consenting patients who are undergoing a routine colonoscopy.\n* Ages between 18-80 years old.\n\nExclusion Criteria:\n\n* Refusal to participate\n* Inability to provide informed consent.\n* History of prior colonic surgery.\n* Poor bowel preparation.\n* Known bowel obstruction.\n* Emergency colonoscopy.","80 Years",{"count":106,"type":20},142,[23],"A colonoscopy is a common procedure used to check for problems in the colon, such as disease or other health issues. Although it's widely used, one challenge is that the flexible tube used in the procedure (called a colonoscope) can sometimes form loops inside the colon. When this happens, pushing the tube further doesn't help it move forward-it just makes the loop bigger, which can make the procedure harder to complete. These loops can also cause more pain for the patient, require more sedation (medication to relax or put the patient to sleep), and increase the time it takes to finish the procedure. Because of this, it's important to find ways to reduce loop formation. Two common methods used in colonoscopies are called air insufflation and water infusion.\n\nThis study will compare the two methods-air vs. water-to see which one causes fewer loops. It will be a randomized controlled trial, meaning participants will be randomly assigned to one of the two methods. The study will involve real patients, and the data will be collected by physicians, residents (doctors in training), and medical students. During the colonoscopies, images from a tool that guides the scope will be recorded on video.\n\nExperienced staff doctors and surgical residents (with at least two months of special training in this procedure) will perform the colonoscopies. Each procedure will be supervised by a team member, such as a medical student, resident, or staff doctor. Afterward, two reviewers who don't know which method was used will watch the videos to look for any loops. They will look for specific types of loops, including n, alpha, reverse alpha, reverse splenic, and gamma loops.\n\nThe study will also track how long it takes to reach the end of the colon (called the cecum), how comfortable the patient was (using a standard rating system already used in all colonoscopies), and how much sedation was needed.",[28],"2025-11-20",{"date":112,"type":34},"2025-11-24",{"date":114,"type":20},"2026-01-01",{"date":116,"type":20},"2027-09-30",{"name":118,"class":41},"Memorial University of Newfoundland"]